HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preference for enzalutamide capsules versus tablet pills in patients with prostate cancer.

AuthorsSahoko Ninomiya, Takashi Kawahara, Tomoyuki Tatenuma, Yasuhide Miyoshi, Hiroshi Miyamoto, Masahiro Yao, Hiroji Uemura
JournalInternational journal of urology : official journal of the Japanese Urological Association (Int J Urol) Vol. 26 Issue 12 Pg. 1161-1162 (12 2019) ISSN: 1442-2042 [Electronic] Australia
PMID31532007 (Publication Type: Clinical Trial, Comparative Study, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Benzamides
  • Capsules
  • Nitriles
  • Placebos
  • Tablets
  • Vitamins
  • Phenylthiohydantoin
  • enzalutamide
Topics
  • Administration, Oral
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents (administration & dosage, adverse effects)
  • Benzamides
  • Capsules
  • Deglutition
  • Dose-Response Relationship, Drug
  • Fatigue (diagnosis, etiology, psychology)
  • Healthy Volunteers
  • Humans
  • Male
  • Nitriles
  • Patient Preference (statistics & numerical data)
  • Phenylthiohydantoin (administration & dosage, adverse effects, analogs & derivatives)
  • Placebos (administration & dosage)
  • Prostatic Neoplasms, Castration-Resistant (complications, drug therapy, psychology)
  • Severity of Illness Index
  • Surveys and Questionnaires (statistics & numerical data)
  • Tablets
  • Vitamins (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: